| Name | Title | Contact Details |
|---|
Build a portfolio of market-leading medical device companies comprised of FDA approved, high revenue-generating technologies and products from the largest market opportunity segments and emerging research and development technologies. Build a portfolio of market-leading medical device companies comprised of FDA approved, high revenue-generating technologies and products from the largest market opportunity segments and emerging research and development technologies.
New England Home Therapies is a Southborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Shafa Medical Clinic Pc is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Integer Holdings Corporation (NYSE:ITGR) is a leader in advanced medical device outsourcing (MDO) and serves its customers by providing comprehensive end-to-end solutions with its unparalleled expertise in innovation and manufacturing. Integer`s vision is to enhance the lives of patients worldwide by being its customer`s partner of choice for innovative medical technologies and services. Additionally, through Electrochem, an Integer company, it develops custom batteries for high-end niche applications in energy, military, and environment markets. The company`s medical device manufacturing brands include Greatbatch™ Medical and Lake Region Medical™.
Lucira Health has developed an at home COVID-19 test kit that delivers PCR quality molecular accuracy in the palm of your hand in 30 minutes or less. Our technology is transforming how we reduce the spread of infectious diseases by bringing accurate, easy-to-use self-testing into the home. This home test kit has not been FDA cleared or approved. This home test kit has been authorized by FDA under EUA. This home test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This home test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or revoked sooner.